Universe Pharmaceuticals INC

NasdaqCM:UPC Stok Raporu

Piyasa değeri: US$2.8m

Universe Pharmaceuticals Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Universe Pharmaceuticals şirketinin toplam hissedar öz sermayesi $26.7M ve toplam borcu $6.5M olup, bu da borç-öz sermaye oranını 24.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $49.4M ve $22.7M dir.

Anahtar bilgiler

24.3%

Borç/özkaynak oranı

US$6.51m

Borç

Faiz karşılama oranın/a
NakitUS$11.39m
EşitlikUS$26.74m
Toplam yükümlülüklerUS$22.69m
Toplam varlıklarUS$49.43m

Son finansal sağlık güncellemeleri

Recent updates

Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Nov 14
Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Sep 27
Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Jul 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

May 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Apr 07
Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

Feb 07
Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Dec 18
There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency

Jul 19

Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

Feb 21
Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Aug 10
We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: UPC 'nin kısa vadeli varlıkları ( $33.5M ) kısa vadeli yükümlülüklerini ( $20.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: UPC şirketinin kısa vadeli varlıkları ( $33.5M ) uzun vadeli yükümlülüklerini ( $2.1M ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: UPC şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: UPC şirketinin borç/öz sermaye oranı son 5 yılda 23.3% seviyesinden 24.3% seviyesine yükseldi.

Borç Kapsamı: UPC 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: UPC şirketinin borçlarına ilişkin faiz ödemelerinin EBIT tarafından iyi bir şekilde karşılanıp karşılanmadığını belirlemek için yeterli veri yok.


Bilanço


Sağlıklı şirketleri keşfedin